Executive Financing Strategy: Equity vs Debt vs Non-Dilutive3 min readUpdated September 2026

Capital Strategy for Growing a Medspa or Outpatient Clinic Group

A medspa or outpatient clinic group has a real financing advantage in cash-pay revenue, but that doesn't automatically make revenue-based financing (RBF) the right fit. Most procedures are collected at the time of service with little reimbursement lag, yet revenue is still procedure-driven and discretionary rather than contractual or subscription-based.

This guide covers where that leaves a growing clinic group, and what actually finances providers, devices and new locations.

Vendors Covered in this Article

Disclosure: We may earn a commission if you buy through some links on this page. It doesn't change what we recommend.

Cash-pay revenue is a real strength, but not the same thing as recurring revenue

Collecting payment at the time of service means you avoid the receivables lag that slows down insurance-reimbursed practices, which genuinely simplifies your cash position. But RBF underwriting looks for revenue that renews predictably, the way a subscription does, and most medspa procedure revenue is one-off and discretionary spend, sensitive to how consumers are feeling about their budgets more broadly. A clinic with a genuine membership or package program, where clients pay monthly or prepay for a bundle of treatments, has a piece of revenue that looks more like what an RBF underwriter wants, but that's typically a minority of total revenue at most practices, not the whole picture.

Provider and injector recruiting is its own capital-intensive line item

Recruiting and onboarding qualified injectors, aestheticians or physician extenders takes real time and money, recruiting costs, training, and a ramp period before a new provider is fully booked, and that ramp cost is a recurring feature of growth in this business, not a one-time expense. Unlike a software company's hiring costs, this ramp is tied directly to a specific revenue-generating role, which makes it a reasonable thing to finance against expected provider productivity once you have a track record showing how quickly new providers typically ramp to full capacity in your practices.

Device financing deserves its own line, separate from working capital

Lasers, body contouring devices and other capital equipment represent a large upfront cost with a defined useful life, and are almost always better financed through equipment leasing or a device-specific loan than through venture debt or RBF. Equipment lenders who understand aesthetic device resale values and depreciation will typically price this more accurately, and more cheaply, than folding it into a broader growth-capital request.

New location buildouts follow the same logic as a de novo dental office

Opening a new clinic location is a capital expenditure and ramp-financing problem, leasehold improvements, equipment, marketing to build a local client base, spent well before that location is generating steady revenue. Project-specific construction or equipment financing, sized to the buildout itself, is the better-fitting tool here, the same way it is for other multi-site practice groups, rather than trying to finance a new, unproven location against the group's existing trailing revenue.

Where do RBF and venture debt each genuinely fit for a clinic group?

RBF becomes realistic for an established, multi-location group with a genuine membership or package revenue base and enough history to show retention, financing working capital or marketing that scales with that recurring piece specifically. Venture debt fits a group that's raised institutional equity and wants corporate-level runway, a shared booking and CRM platform, centralized marketing, back-office systems, across the whole group rather than financing any single location or device purchase.

A quick way to sort your own ask

Work through this before applying anywhere:

  • What share of revenue is genuinely recurring membership or package business versus one-off procedure revenue?
  • Is the need a new location, which fits project-specific buildout financing?
  • Is it a device, which fits equipment leasing sized to that specific asset?
  • Have you raised institutional equity that would make venture debt relevant for corporate-level platform investment?

Discretionary spend sensitivity is a real underwriting factor here

Because most medspa procedures are elective and paid out of pocket, revenue can soften when consumers pull back on discretionary spending in a way that a medical practice billing insurance for necessary care generally doesn't experience to the same degree. A lender evaluating this business, whether for RBF, a device loan, or a buildout facility, will typically want to see how revenue held up through a prior soft patch, if you have one on record, since that tells them more about durability than a strong recent quarter alone does. Building that resilience narrative into how you present the business, with real historical data covering at least one softer stretch rather than reassurance alone, tends to get meaningfully better terms from whoever is evaluating the request.

This is also a good reason to grow the membership and package share of revenue deliberately over time, since a higher proportion of prepaid, recurring revenue cushions the practice against exactly the kind of discretionary pullback that pure procedure revenue is most exposed to.

Executive Capability Standard

What Good Looks Like

Good here means separating genuinely recurring membership revenue from one-off procedure revenue, and financing new locations and devices through the project-specific and equipment tools built for each, rather than one blended growth-capital request.

Building The Capability (5-Stage Skill Ladder)

1. Learn:Learn how RBF underwriters distinguish membership or package revenue from one-off procedure revenue in consumer healthcare businesses.
2. Do Manually:Track your provider ramp period by hand across recent hires to see how long it actually takes a new injector or aesthetician to reach full booking capacity.
3. Delegate:Bring in a fractional CFO with multi-site healthcare or aesthetics experience to separate membership revenue for an RBF conversation from procedure and device costs.
4. Automate:Set your booking and point-of-sale system to tag membership and package revenue separately from one-off procedure revenue automatically.
5. Buy:Work with an equipment lender who understands aesthetic device resale values, and a project lender for buildouts, rather than financing both through one generic facility.

How to Get Started

Disclosure: We may earn a commission if you buy through some links on this page. It doesn't change what we recommend.

Frequently Asked Questions

Does a membership program make a medspa a better RBF candidate?

Yes, a membership program helps, because membership revenue is the recurring piece an RBF underwriter can size an advance against. It typically needs at least a year of consistent enrollment and renewal history before a lender will treat it as reliable enough to lend against.

Should I finance laser and device purchases the same way I finance a new location?

No, they're different problems. A device has a specific resale value and useful life that an equipment lender prices directly, while a new location involves leasehold improvements and a longer ramp period that a construction or buildout loan is built to cover.

How long does it typically take a new injector to reach full booking capacity?

It varies by market and by how the practice supports new provider marketing, so most groups track the ramp period explicitly. The ramp directly affects how quickly a recruiting investment starts paying for itself and how to budget for the gap in the meantime.

About the numbers

This guide doesn't quote a sourced benchmark. Figures in it are estimates or general guidance, so check them against your own numbers.

Related Guides